• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NGQ1:GR

1.428 EUR 0.208 12.71%

As of 10:14:50 ET on 10/23/2014.

Snapshot for Medicure Inc (NGQ1)

Open: 1.575 Day's Range: 1.428 - 1.578 Volume: 0
Previous Close: 1.636 52wk Range: 0.123 - 1.999 1-Yr Rtn: +1,033.33%

Stock Chart for NGQ1

No chart data available.
  • NGQ1:GR 1.499
  • 1D
  • 1M
  • 1Y
1.636
Interactive NGQ1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NGQ1

Current P/E Ratio (ttm) -
Estimated P/E(05/2015) 16.9166
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (05/2015) 0.1200
Est. PEG Ratio -
Market Cap (M EUR) 17.44
Shares Outstanding (M) 12.21
30 Day Average Volume 476
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NGQ1

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for NGQ1

Medicure Inc. is a cardiovascular drug discovery and development company focused on developing therapeutics for unmet needs in the field of cardiovascular medicine. The Company's current focus is on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.

Albert D FriesenChairman/CEO/FounderDawson J ReimerPresident/COO
James F KinleyCFO/Secretary
More Company Profile & Key Executives for NGQ1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil